Press Release: Xcelthera : Xcelthera Inc Secures First U.S. Patent for Large-Scale Production of High Quality Human Embryonic Stem Cells and their Neuronal and Heart Muscle Cell Therapy Products

Xcelthera Inc and its joint research partner San Diego Regenerative Medicine Institute are granted U.S. Patent No. 8,716,017 entitled, “Technologies, Methods, and Products of Small Molecule-Directed Tissue and Organ Regeneration from Human Pluripotent Stem Cells.”(PRWeb May 08, 2014)Read the full story at http://www.prweb.com/releases/2014/05/prweb11827559.htm